In addition to the classical mutants and the widely used GAL4-UAS targeted expression system combined with RNAi, introduction of CRISPR/Cas9 system to Drosophila in the past several years has enabled the development of more accurate Drosophila models for DEE carrying the same mutations found in patients. Here, LGALS4 is linked to developmental and epileptic encephalopathy.